Newsroom

For media inquiries, please contact 340B Health Senior Vice President of Communications Jon Tilton at jon.tilton@340bhealth.org​​​​​​​ or 202-536-2285.

• 340B HEALTH BOARD ELECTS TWO NEW MEMBERS

  May 21, 2025 in 340B Health News Releases

• 340B HEALTH RESPONDS TO FEDERAL COURT DECISION ON DRUGMAKERS’ REBATE SCHEMES

  May 16, 2025 in 340B Health News Releases

• 340B HEALTH RESPONDS TO SEN. CASSIDY’S REPORT ON THE 340B DRUG PRICING PROGRAM

  April 24, 2025 in 340B Health News Releases

• 340B HEALTH SUBMITS MOTIONS TO INTERVENE IN ALL DRUGMAKER REBATE LAWSUITS

  February 06, 2025 in 340B Health News Releases

• 340B HEALTH FILES MOTION TO INTERVENE IN J&J REBATE LAWSUIT

  January 30, 2025 in 340B Health News Releases

• 340B HEALTH BOARD ELECTS TWO NEW MEMBERS

  December 20, 2024 in 340B Health News Releases

• 340B HEALTH STATEMENT ON 340B DRUG PURCHASE DATA FOR 2023

  October 21, 2024 in 340B Health News Releases

• 340B HEALTH APPLAUDS HRSA’S ACTION TO PROTECT 340B FROM J&J’S REBATE SCHEME

  September 27, 2024 in 340B Health News Releases

• SENATE COMPANION BILL WOULD END DRUG COMPANY RESTRICTIONS ON 340B

  September 11, 2024 in 340B Health News Releases

• 340B HEALTH URGES HRSA TO BLOCK J&J PLAN TO REPLACE 340B DISCOUNTS WITH REBATES

  August 23, 2024 in 340B Health News Releases

• 340B HEALTH BOARD ELECTS TWO NEW MEMBERS

  May 30, 2024 in 340B Health News Releases

• STATEMENT ON NEW FEDERAL LEGISLATION TO RESTRICT 340B HOSPITAL ELIGIBILITY

  May 28, 2024 in 340B Health News Releases